Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease. (2021)
Attributed to:
Newton001 SLEEP DEPRIVATION IN PARKINSON'S DISEASE: BRAZIL AND UNITED KINGDOM RESEARCH NETWORK
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13195-020-00741-z
PubMed Identifier: 33422142
Publication URI: http://europepmc.org/abstract/MED/33422142
Type: Journal Article/Review
Volume: 13
Parent Publication: Alzheimer's research & therapy
Issue: 1